chr7-140734774-C-A

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_004333.6(BRAF):​c.2128-4G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). The gene BRAF is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.016 ( 0 hom., cov: 0)
Exomes 𝑓: 0.021 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

BRAF
NM_004333.6 splice_region, intron

Scores

2
Splicing: ADA: 0.00007941
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.942

Publications

3 publications found
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cardiofaciocutaneous syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • LEOPARD syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Noonan syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • anaplastic astrocytoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 7-140734774-C-A is Benign according to our data. Variant chr7-140734774-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 377569.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004333.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
NM_001374258.1
MANE Plus Clinical
c.2248-4G>T
splice_region intron
N/ANP_001361187.1A0A2R8Y8E0
BRAF
NM_004333.6
MANE Select
c.2128-4G>T
splice_region intron
N/ANP_004324.2
BRAF
NM_001374244.1
c.2248-4G>T
splice_region intron
N/ANP_001361173.1A0A2U3TZI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
ENST00000644969.2
MANE Plus Clinical
c.2248-4G>T
splice_region intron
N/AENSP00000496776.1A0A2R8Y8E0
BRAF
ENST00000646891.2
MANE Select
c.2128-4G>T
splice_region intron
N/AENSP00000493543.1P15056
BRAF
ENST00000288602.11
TSL:1
c.2248-4G>T
splice_region intron
N/AENSP00000288602.7A0A2U3TZI2

Frequencies

GnomAD3 genomes
AF:
0.0164
AC:
398
AN:
24332
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0303
Gnomad AMI
AF:
0.0364
Gnomad AMR
AF:
0.0114
Gnomad ASJ
AF:
0.00824
Gnomad EAS
AF:
0.00764
Gnomad SAS
AF:
0.0167
Gnomad FIN
AF:
0.00345
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0133
Gnomad OTH
AF:
0.0238
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0205
AC:
15076
AN:
733840
Hom.:
0
Cov.:
23
AF XY:
0.0191
AC XY:
7061
AN XY:
369880
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0146
AC:
231
AN:
15850
American (AMR)
AF:
0.00374
AC:
57
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00899
AC:
114
AN:
12676
East Asian (EAS)
AF:
0.00612
AC:
135
AN:
22058
South Asian (SAS)
AF:
0.0113
AC:
406
AN:
35772
European-Finnish (FIN)
AF:
0.00547
AC:
129
AN:
23592
Middle Eastern (MID)
AF:
0.0136
AC:
36
AN:
2646
European-Non Finnish (NFE)
AF:
0.0234
AC:
13470
AN:
575678
Other (OTH)
AF:
0.0164
AC:
498
AN:
30322
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.264
Heterozygous variant carriers
0
1720
3440
5160
6880
8600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0164
AC:
398
AN:
24336
Hom.:
0
Cov.:
0
AF XY:
0.0165
AC XY:
189
AN XY:
11428
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0303
AC:
161
AN:
5308
American (AMR)
AF:
0.0109
AC:
20
AN:
1842
Ashkenazi Jewish (ASJ)
AF:
0.00824
AC:
6
AN:
728
East Asian (EAS)
AF:
0.00776
AC:
7
AN:
902
South Asian (SAS)
AF:
0.0169
AC:
15
AN:
886
European-Finnish (FIN)
AF:
0.00345
AC:
4
AN:
1158
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
52
European-Non Finnish (NFE)
AF:
0.0133
AC:
174
AN:
13050
Other (OTH)
AF:
0.0233
AC:
7
AN:
300
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.279
Heterozygous variant carriers
0
37
74
111
148
185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00978
Hom.:
0

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
BRAF-related disorder (1)
-
1
-
Intellectual disability (1)
-
-
1
Noonan syndrome and Noonan-related syndrome (1)
-
-
1
not provided (1)
-
-
1
RASopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
7.2
DANN
Benign
0.53
PhyloP100
0.94
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000079
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs956143558; hg19: chr7-140434574; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.